Search

Your search keyword '"Phosphotransferases -- Reports -- Analysis"' showing total 14 results
Start Over Descriptor "Phosphotransferases -- Reports -- Analysis" Journal angiogenesis weekly
14 results on '"Phosphotransferases -- Reports -- Analysis"'

1. Emory University, Aflac Cancer Center and Blood Disorders Service publishes research in medulloblastomas

Subjects
Analysis, Reports, Universities and colleges -- Reports -- Analysis, Cancer -- Reports -- Analysis, Phosphotransferases -- Reports -- Analysis, Cancer research -- Reports -- Analysis, Oncology, Experimental -- Reports -- Analysis, Cancer -- Reports -- Analysis -- Research
Abstract

Research findings, 'Heterozygosity for Pten promotes tumorigenesis in a mouse model of medulloblastoma,' are discussed in a new report. According to a study from the United States, 'Recent publications have [...]

Published
2010

2. Researchers from Midwestern University provide details of new studies and findings in the area of rheumatoid arthritis

Subjects
Analysis, Research, Reports, Rheumatoid arthritis -- Research -- Reports -- Analysis, Universities and colleges -- Reports -- Analysis, Rheumatoid factor -- Reports -- Analysis, Phosphotransferases -- Reports -- Analysis, Cytological research -- Reports -- Analysis, Cell research -- Reports -- Analysis
Abstract

A new study, 'Fractalkine-induced endothelial cell migration requires MAP kinase signaling,' is now available. 'Angiogenesis is a well-established characteristic in the rheumatoid arthritis (RA) synovial pannus. We have previously demonstrated [...]

Published
2010

3. Studies from Eisai Co., Ltd. add new findings in the area of vascular endothelial growth factor

Subjects
Eisai Company Ltd. -- Reports, Analysis, Development and progression, Reports, Cancer treatment -- Reports -- Analysis, Cancer -- Development and progression -- Reports -- Analysis, Drugs -- Reports -- Analysis, Phosphotransferases -- Reports -- Analysis, Xenotransplantation -- Reports -- Analysis, Cytological research -- Reports -- Analysis, Vascular endothelial growth factor -- Reports -- Analysis, Pharmaceutical industry -- Reports -- Analysis, Cell research -- Reports -- Analysis, Cancer -- Care and treatment -- Development and progression -- Reports -- Analysis
Abstract

Fresh data on vascular endothelial growth factor are presented in the report 'E7050: a dual c-Met and VEGFR-2 tyrosine kinase inhibitor promotes tumor regression and prolongs survival in mouse xenograft [...]

Published
2010

4. Research from Institute of Cancer Research yields new findings on carcinoma therapy

Subjects
Analysis, Reports, Cancer treatment -- Reports -- Analysis, Endothelial growth factors -- Reports -- Analysis, Liver cancer -- Reports -- Analysis, Neovascularization -- Reports -- Analysis, Phosphotransferases -- Reports -- Analysis, Cancer research -- Reports -- Analysis, Xenotransplantation -- Reports -- Analysis, Vascular endothelial growth factor -- Reports -- Analysis, Carcinoma -- Reports -- Analysis, Antineoplastic agents -- Reports -- Analysis, Cancer -- Care and treatment -- Research -- Reports -- Analysis, Antimitotic agents -- Reports -- Analysis, Oncology, Experimental -- Reports -- Analysis
Abstract

Data detailed in 'Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma' have been presented. 'Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide. Vascular endothelial [...]

Published
2010

5. Researchers from Mario Negri Institute for Pharmacological Research report on findings in ovarian cancer therapy

Subjects
Analysis, Reports, Cancer treatment -- Reports -- Analysis, Endothelial growth factors -- Reports -- Analysis, Neovascularization -- Reports -- Analysis, Drugs -- Reports -- Analysis, Phosphotransferases -- Reports -- Analysis, Cancer research -- Reports -- Analysis, Antineoplastic agents -- Reports -- Analysis, Ovarian cancer -- Reports -- Analysis, Oncology, Experimental -- Reports -- Analysis, Cancer -- Care and treatment -- Research, Antimitotic agents -- Reports -- Analysis
Abstract

Researchers detail in 'The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma,' new data in ovarian cancer. 'This study was [...]

Published
2009

6. Studies from University of Texas describe new findings in vascular endothelial growth factor

Subjects
Analysis, Reports, Universities and colleges -- Reports -- Analysis, Bloodborne diseases -- Reports -- Analysis, Neovascularization -- Reports -- Analysis, Phosphotransferases -- Reports -- Analysis, Vascular endothelial growth factor -- Reports -- Analysis, Platelet-derived growth factor -- Reports -- Analysis, Blood-borne diseases -- Reports -- Analysis
Abstract

'Epidermal cell migration is critical for restoration of tissue structure and function after damage [1]. However, the mechanisms by which differentiated cells neighboring the wound sense the wound and assume [...]

Published
2009

7. Research from K.W. Ong and co-researchers yields new findings on cancer

Subjects
Analysis, Reports, Cancer treatment -- Reports -- Analysis, Endothelial growth factors -- Reports -- Analysis, Neovascularization -- Reports -- Analysis, Cancer -- Reports -- Analysis, Phosphotransferases -- Reports -- Analysis, Cancer research -- Reports -- Analysis, Vascular endothelial growth factor -- Reports -- Analysis, Organ transplantation -- Reports -- Analysis, Transplantation of organs, tissues, etc. -- Reports -- Analysis, Oncology, Experimental -- Reports -- Analysis, Cancer -- Care and treatment -- Reports -- Analysis -- Research
Abstract

'EBV-positive smooth muscle tumor (EBV+SMT) is a rare disease with no established therapy. We describe the largest single institution analysis in renal transplant recipients,' scientists writing in the journal Clinical [...]

Published
2009

8. Researchers from Nanjing University describe findings in vascular endothelial growth factor

Subjects
Nanjing University -- Reports, Analysis, Reports, Universities and colleges -- Reports -- Analysis, Neovascularization -- Reports -- Analysis, Simvastatin -- Reports -- Analysis, Drugs -- Reports -- Analysis, Phosphotransferases -- Reports -- Analysis, Antilipemic agents -- Reports -- Analysis, Vascular endothelial growth factor -- Reports -- Analysis
Abstract

'HMG-CoA reductase inhibitor (statins) are known to have pleiotropic effects. We examined the effect and mechanism of simvastatin on peripheral endothelial progenitor cells (EPCs),' scientists writing in the journal Applied [...]

Published
2009

9. Report summarizes angiogenesis study findings from Osaka University

Subjects
Osaka University -- Reports, Analysis, Reports, Universities and colleges -- Reports -- Analysis, Endothelial growth factors -- Reports -- Analysis, Neovascularization -- Reports -- Analysis, Sphingosine -- Reports -- Analysis, Phosphotransferases -- Reports -- Analysis, Cytological research -- Reports -- Analysis, Vascular endothelial growth factor -- Reports -- Analysis, Cell research -- Reports -- Analysis
Abstract

According to recent research published in the journal Arteriosclerosis Thrombosis and Vascular Biology, 'In the functional screening of a human heart cDNA library to identify a novel antiangiogenic factor, the [...]

Published
2009

10. Studies from University of Duisburg-Essen reveal new findings on vascular endothelial growth factor

Subjects
Analysis, Reports, Universities and colleges -- Reports -- Analysis, Bladder cancer -- Reports -- Analysis, Neovascularization -- Reports -- Analysis, Phosphotransferases -- Reports -- Analysis, Vascular endothelial growth factor -- Reports -- Analysis
Abstract

According to a study from Essen, Germany, 'Angiogenesis plays a critical role in tumor growth. VEGF, angiopoietins (Ang-1, Ang-2) and their tyrosine kinase receptor Tie2 are major regulators of angiogenesis.' [...]

Published
2009

11. New findings from Yale University describe advances in vascular endothelial growth factor

Subjects
Yale University -- Reports, Analysis, Reports, Cancer treatment -- Reports -- Analysis, Universities and colleges -- Reports -- Analysis, Growth factors -- Reports -- Analysis, Neovascularization -- Reports -- Analysis, Cancer -- Reports -- Analysis, Drugs -- Reports -- Analysis, Phosphotransferases -- Reports -- Analysis, Medical research -- Reports -- Analysis, Vascular endothelial growth factor -- Reports -- Analysis, Melanoma -- Reports -- Analysis, Medicine, Experimental -- Reports -- Analysis, Cancer -- Care and treatment -- Reports -- Analysis
Abstract

According to a study from the United States, 'Sorafenib, a multitarget kinase inhibitor, inhibits members of the mitogen-activated protein kinase (MAPK) pathway and receptor tyrosine kinases, including vascular endothelial growth [...]

Published
2009

12. Researchers from Shandong University report on findings in angiogenesis

Subjects
Analysis, Reports, Universities and colleges -- Reports -- Analysis, Neovascularization -- Reports -- Analysis, Phosphotransferases -- Reports -- Analysis, Cardiovascular diseases -- Reports -- Analysis
Abstract

'Ischemic heart disease is one of the leading causes of morbidity and mortality worldwide. Shu-inai-tang (SMT) is a traditional Chinese medicine for the treatment of ischemic heart disease,' scientists in [...]

Published
2009

13. Findings in hypertension reported from State University of New York

Subjects
State University of New York -- Reports, Analysis, Reports, Universities and colleges -- Reports -- Analysis, Hypertension -- Reports -- Analysis, Neovascularization -- Reports -- Analysis, Kidney -- Reports -- Analysis, Phosphotransferases -- Reports -- Analysis, Medical research -- Reports -- Analysis, Medicine, Experimental -- Reports -- Analysis, Kidneys -- Reports -- Analysis
Abstract

'Sunitinib is a multitargeted tyrosine kinase inhibitor used in the treatment of metastatic renal cell carcinoma (RCC) and gastrointestinal stromal tumor (GIST), and undergoing evaluation for other malignancy. Hypertension is [...]

Published
2009

14. Findings from University of Colorado, Colorado Health Sciences Center advance knowledge in pharmacokinetics

Subjects
University of Colorado Denver -- Reports, Analysis, Reports, Universities and colleges -- Reports -- Analysis, Endothelial growth factors -- Reports -- Analysis, Neovascularization -- Reports -- Analysis, Drugs -- Reports -- Analysis, Cancer -- Reports -- Analysis, Phosphotransferases -- Reports -- Analysis, Docetaxel -- Reports -- Analysis
Abstract

A report, 'Pharmacokinetic-directed dosing of vandetanib and docetaxel in a mouse model of human squamous cell carcinoma,' is newly published data in Molecular Cancer Therapeutics. According to a study from [...]

Published
2008

Catalog

Books, media, physical & digital resources
See catalog results